Consensus recommendations for diagnosis and treatment of Multiple Sclerosis: 2023 revision of the MENACTRIMS guidelines-Reference-Cited by-同舟云学术

Consensus recommendations for diagnosis and treatment of Multiple Sclerosis: 2023 revision of the MENACTRIMS guidelines

Published:2024-03 Issue: Volume:83 Page:105435
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Yamout B.^ORCID,Al-Jumah M.,Sahraian M.A.,Almalik Y,Khaburi J. Al,Shalaby N.,Aljarallah S,Bohlega S.,Dahdaleh M.,Almahdawi A.,Khoury S.J.,Koussa S.,Slassi E.,Daoudi S,Aref H.,Mrabet S.,Zeineddine M.^ORCID,Zakaria M.,Inshasi J.,Gouider R.,Alroughani R.

Publisher

Elsevier BV

Reference248 articles.

1. The prevalence of Multiple Sclerosis in the Middle East;Al-Hashel;Neuroepidemiology,2008

2. Hematopoietic stem cell therapy for autoimmune diseases–Clinical experience and mechanisms;Alexander;J. Autoimmun.,2018

3. Autologous hematopoietic stem cell transplantation following pulsed cyclophosphamide in a severely disabled patient with malignant Multiple Sclerosis;Alix;J. Neurol.,2013

4. Rituximab versus fingolimod after natalizumab in Multiple Sclerosis patients;Alping;Ann. Neurol.,2016

5. Increasing prevalence and incidence rates of Multiple Sclerosis in Kuwait;Alroughani;Mult. Scler.,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practical Recommendations from the Gulf Region on the Therapeutic Use of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis: Impact of the Latest Real-World Evidence on Clinical Practice;Neurology and Therapy;2024-08-03

2. Disease modifying treatment guidelines for multiple sclerosis in the United Arab Emirates;Multiple Sclerosis and Related Disorders;2024-08

3. Moving towards a new era for the treatment of neuromyelitis optica spectrum disorders;Journal of Neurology;2024-05-21